Background Clinical pharmacy services have potential to contribute significantly to the
multidisciplinary team providing safe, effective and economic care for patients. Given recent …

Introduction Adjusting doses of renally cleared medications and/or avoidance of nephrotoxic
medications are standard clinical practices in chronic kidney disease (CKD), albeit the …

Introduction Globally, chronic kidney disease (CKD) is one of the leading causes of mortality.
Impaired renal function makes CKD patients vulnerable to drug-related problems (DRPs) …

Background The use of nephrotoxic drugs has the potential to accelerate the loss of kidney
function and increase the risk of end-stage renal disease. Objectives To determine the …

Objectives Renal insufficiency is common among older patients and, accordingly, renally
excreted drugs may require an adjustment in dosage for them. Rates of non‐adherence to …

Background Chronic kidney disease (CKD) is a major public health concern due to its high
mortality risk, high hospitalization rates and cost, and low life expectancy. Thus, CKD …

Background Medicine shortages are often described in plain numbers, suggesting all
shortages have a uniform impact. However, some shortages have a direct and serious effect …

Background Chronic kidney disease (CKD) poses a significant public health challenge. CKD
patients have compromised renal function, which not only alters the pharmacokinetics of …

Aim To investigate whether it is feasible to perform pharmacogenetic testing and implement
the test results as part of medication reviews during hospitalization of multimorbid patients …

Purpose To investigate the puncture accuracy and feasibility of contrast-enhanced
ultrasound (CEUS) guided percutaneous nephrolithotomy (PCNL) in flank position for …